Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Nature Communications|June 29, 2018
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapyAli Talebi, Jonas Dehairs, Florian Rambow, et al.
Cancer Research|May 14, 2009
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein responseAngelika Szokalska, Marcin Makowski, Dominika Nowis, et al.
Acta Neuropathologica|January 3, 2024
Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCsYingli Zhu, Thibaut Burg, Katrien Neyrinck, et al.
Nature Communications|November 12, 2024
Simultaneous detection of membrane contact dynamics and associated Ca<sup>2+</sup> signals by reversible chemogenetic reportersPaloma García Casas, Michela Rossini, Linnea Påvénius, et al.
Cancer Cell|August 14, 2014
Tumor vessel normalization by chloroquine independent of autophagyHannelore Maes, Anna Kuchnio, Aleksandar Peric, et al.
Nature Communications|May 19, 2022
Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesisOdeta Meçe, Diede Houbaert, Maria-Livia Sassano, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancerJenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, et al.
Microbial Cell Factories|February 3, 2012
The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GGSarah Lebeer, Ingmar J J Claes, Crina I A Balog, et al.
JCI Insight|July 30, 2024
Missense variants in CMS22 patients reveal that PREPL has both enzymatic and nonenzymatic functionsYenthe Monnens, Anastasia Theodoropoulou, Karen Rosier, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2023
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapyAli Talebi, Vincent de Laat, Xander Spotbeen, et al.
Pageof 20